title: Temporary anti-CD-25 treatment results in tolerance development in syngeneically grafted autoimmune diabetic recipients.
authors.affiliation: Institute of Immunology, Free University Berlin, Germany.
authors.forename: H J
authors.initials: HJ
authors.lastname: Hahn
authors.forename: B
authors.initials: B
authors.lastname: Kuttler
authors.forename: A
authors.initials: A
authors.lastname: Dunger
authors.forename: S
authors.initials: S
authors.lastname: Lucke
authors.forename: H D
authors.initials: HD
authors.lastname: Volk
authors.forename: T
authors.initials: T
authors.lastname: Diamantstein
mesh_terms: D000818:Animals; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D003524:Cyclosporins / Q000627:therapeutic use; D003921:Diabetes Mellitus, Experimental / Q000276:immunology / Q000601:surgery*; D007108:Immune Tolerance; D007165:Immunosuppression Therapy; D016381:Islets of Langerhans Transplantation / Q000276:immunology*; D017710:Lymphocyte Transfusion; D051381:Rats; D011913:Rats, Inbred BB; D015375:Receptors, Interleukin-2 / Q000276:immunology*; D014185:Transplantation, Isogeneic
chemical_list: D000911:Antibodies, Monoclonal; D003524:Cyclosporins; D015375:Receptors, Interleukin-2